Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero

References

• Diamanti-Kandarakis E, Economou F, Palimeri S, Christakou C. Metformin in polycystic ovary syndrome. Ann NY Acad Sci 2010;1205:192–8.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17:2573–9.
   PubMed Web of Science ®Google Scholar
• Kjotrod SB, Sunde A, von During V, Carlsen SM. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome. Fertil Steril 2009;91:500–8.
   PubMed Web of Science ®Google Scholar
• Fougner KJ, Vanky E, Carlsen SM. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest 2008;68:771–6.
   PubMed Web of Science ®Google Scholar
• Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogoy K, Kleggetveit O, Hjelle S, von Brandis P, Eikeland T, Flo K, Berg KF, Bunford G, Lund A, Bjerke C, Almas I, Berg AH, Danielson A, Lahmami G, Carlsen SM. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448–55.
   PubMed Web of Science ®Google Scholar
• Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83:1575–8.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Bornovali S, Pranikoff J, Goldenberg N, Dharashivkar S, Wang P. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabetic Med 2004;21:829–36.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19:1323–30.
   PubMed Web of Science ®Google Scholar
• Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. South Afr Med J [Suid-Afrikaanse tydskrif vir geneeskunde] 1984;65:635–7.
   PubMed Web of Science ®Google Scholar
• Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011;34:2279–84.
   PubMed Web of Science ®Google Scholar
• Carlsen SM, Vanky E. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns. Hum Reprod 2010;25:786–90.
   PubMed Web of Science ®Google Scholar
• Vanky E, Carlsen SM. Androgens and antimullerian hormone in mothers with polycystic ovary syndrome and their newborns. Fertil Steril 2012;97:509–15.
   PubMed Web of Science ®Google Scholar
• Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004;19:1734–40.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–10.
   PubMed Web of Science ®Google Scholar
• Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Statistics Med 1998;17:407–29.
   PubMed Web of Science ®Google Scholar
• Brannsether B, Roelants M, Bjerknes R, Juliusson PB. Waist circumference and waist-to-height ratio in Norwegian children 4–18 years of age: reference values and cut-off levels. Acta Paediatr 2011;100:1576–82.
   PubMed Web of Science ®Google Scholar
• Jones RH, Ozanne SE. Fetal programming of glucose- insulin metabolism. Mol Cell Endocrinol 2009;297:4–9.
   PubMed Web of Science ®Google Scholar
• Wulffele MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Internal Med 2004;256:1–14.
   Google Scholar
• Carlsen SM, Rossvoll O, Bjerve KS, Folling I. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease. J Internal Med 1996;239:227–33.
   Google Scholar
• Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS, Daniels SR. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 2007;119:237–46.
   PubMed Web of Science ®Google Scholar
• Shields BM, Knight B, Hopper H, Hill A, Powell RJ, Hattersley AT, Clark PM. Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care 2007;30:2661–6.
   PubMed Web of Science ®Google Scholar
• Murphy MJ, Metcalf BS, Voss LD, Jeffery AN, Kirkby J, Mallam KM, Wilkin TJ. Girls at five are intrinsically more insulin resistant than boys: the programming hypotheses revisited – The EarlyBird Study (EarlyBird 6). Pediatrics 2004;113:82–6.
   PubMed Web of Science ®Google Scholar